Rigel Pharmaceuticals Inc (RIGL) financials · rev $294.3M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Rigel Pharmaceuticals Inc (RIGL) rev $294.3M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $294.3M | $179.3M |
| Cost of Revenue | $19.6M | $18.6M |
| Gross Profit | $274.7M | $160.6M |
| Operating Income | $125.5M | $24.2M |
| Net Income | $367.0M | $17.5M |
| EPS (Diluted) | $19.48 | $0.99 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $513.6M | $164.0M |
| Current Assets | $240.2M | $135.1M |
| Cash & Equivalents | $40.6M | $56.7M |
| Inventory | $11.5M | $6.00M |
| PP&E | $30.0K | $92.0K |
| Total Liabilities | $122.1M | $160.7M |
| Current Liabilities | $99.2M | $63.3M |
| Long-term Debt | $52.5M | $60.0M |
| Total Debt | $52.5M† | $60.0M† |
| Shareholders' Equity | $391.5M | $3.29M |
| Retained Earnings | -$1.02B | -$1.39B |
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $75.7M | $31.5M |
| Investing Cash Flow | -$92.4M | $4.13M |
| Financing Cash Flow | $601.0K | -$11.6M |
FAQ
What is RIGL P/E and revenue?
Rigel Pharmaceuticals Inc (RIGL) rev $294.3M.
What is RIGL revenue?
Rigel Pharmaceuticals Inc last cached revenue is $294.3M (FY2025).
Is RIGL profitable?
Rigel Pharmaceuticals Inc last cached net income is $367.0M (FY2025).
What are RIGL total assets?
Rigel Pharmaceuticals Inc last cached total assets are $513.6M (FY2025).
What is RIGL free cash flow?
No cached cash-flow row for RIGL yet.
Not investment advice. Cached statements, not a live tape.